Late consequences of the fontan operation

Circulation

Volumn 130, Issue 17, 2014, Pages 1525-1528

  Rychik, Jack ^a,b   Goldberg, David J ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 1 ANTITRYPSIN; ASPARTATE AMINOTRANSFERASE; BUDESONIDE; PLASMA PROTEIN; SILDENAFIL; GLUCOCORTICOID; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; VASODILATOR AGENT;

ABDOMINAL RADIOGRAPHY; ABDOMINAL SWELLING; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CENTRAL VENOUS PRESSURE; CHRONIC VEIN INSUFFICIENCY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EXERCISE; FECES ANALYSIS; FONTAN PROCEDURE; FORWARD HEART FAILURE; FULMINANT HEPATIC FAILURE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GLENN SHUNT; HEART CATHETERIZATION; HEART OUTPUT; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; ILEUM; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LYMPHANGIECTASIS; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOSING GASTROENTEROPATHY; QUALITY OF LIFE; THROMBOCYTE COUNT; THROMBOEMBOLISM; TRICUSPID VALVE REGURGITATION; VENOUS RETURN; ADVERSE EFFECTS; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS;

ADOLESCENT; BUDESONIDE; FONTAN PROCEDURE; GLUCOCORTICOIDS; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; MALE; PIPERAZINES; POSTOPERATIVE COMPLICATIONS; PURINES; SULFONES; VASODILATOR AGENTS;

EID: 84922042484     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.005341     Document Type: Article

References (20)

1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26:240-248.
2. Khambadkone S, Li J, De Leval MR, Cullen S, Deanfield JE, Redington AN. Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation. 2003;107:3204-3208.
3. Sarkola T, Jaeggi E, Slorach C, Hui W, Bradley T, Redington AN. Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up. Heart Vessels. 2013;28:66-75.
4. Paridon SM, Mitchell PD, Colan SD, Williams RV, Blaufox A, Li JS, Margossian R, Mital S, Russell J, Rhodes J; Pediatric Heart network Investigators. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol. 2008;52:99-107.
5. Giardini A, Hager A, Pace Napoleone C, Picchio FM. natural history of exercise capacity after the Fontan operation: a longitudinal study. Ann Thorac Surg. 2008;85:818-821.
6. Fernandes SM, Alexander ME, Graham DA, Khairy P, Clair M, Rodriguez E, Pearson DD, Landzberg MJ, Rhodes J. Exercise testing identifes patients at increased risk for morbidity and mortality following Fontan surgery. Congenit Heart Dis. 2011;6:294-303.
7. Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL. Thrombus formation after the Fontan operation. Ann Thorac Surg. 2001;71:1990-1994.
8. Valente AM, Bhatt AB, Cook S, Earing MG, Gersony DR, Aboulhosn J, Opotowsky AR, Lui G, Gurvitz M, Graham D, Fernandes SM, Khairy P, Webb G, Gerhard-Herman M, Landzberg MJ; AARCC (Alliance for Adult Research in Congenital Cardiology) Investigators. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol. 2010;56:144-150.
9. Odegard KC, Zurakowski D, Dinardo JA, Castro RA, McGowan FX Jr, Neufeld EJ, Laussen PC. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg. 2009;137:934-941.
10. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, Landzberg MJ. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85-92.
11. Varma C, Warr MR, Hendler AL, Paul N S, Webb GD, Therrien J. Prevalence of "silent" pulmonary emboli in adults after the Fontan operation. J Am Coll Cardiol. 2003;41:2252-2258.
12. Rychik J, Gui-Yang S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am J Cardiol. 2002;90:672-674.
13. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg. 2006;82:695-700.
14. Thacker D, Patel A, Dodds K, Goldberg DJ, Semeao E, Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg. 2010;89:837-842.
15. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005;129:1348-1352.
16. McCrindle BW, Manlhiot C, Cochrane A, Roberts R, Hughes M, Szechtman B, Weintraub R, Andrew M, Monagle P; Fontan Anticoagulation Study Group. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J Am Coll Cardiol. 2013;61:346-353.
17. Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J. Impact of oral sildenafl on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation. 2011;123:1185-1193.
18. Apostolopoulou SC, Papagiannis J, Rammos S. Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation. J Heart Lung Transplant. 2005;24:1174-1176.
19. Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells RG. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol. 2012;33:1001-1012.
20. Simpson KE, Esmaeeli A, Khanna G, White F, Turnmelle Y, Eghtesady P, Boston U, Canter CE. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33:170-177.